Business Wire

WA-AMAZON-WEB-SERVICES

Share
AWS and Formula 1 Announce New Racing Performance Stats for 2020 Season

Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), and Formula 1 (F1) (NASDAQ: FWONA, FWONK) are introducing six new, real-time racing statistics that will roll out through the 2020 season, beginning with the launch of “Car Performance Scores” at the season opening Grand Prix in Spielberg, Austria July 3-5. “Car Performance Scores” isolate an individual car’s performance and allows race fans to compare its performance to that of different vehicles head-to-head. The new set of statistics to be released this season will use a range of AWS services, including machine learning, to give fans the ability to compare their favorite drivers and cars and better predict race outcomes. Learn more at: https://aws.amazon.com/f1/ .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200623005380/en/

With 300 sensors on each F1 race car generating more than 1.1M data points per second transmitted from the cars to the pit, Formula 1 is a truly data-driven sport where much of the thrill comes from extracting exciting details on performance statistics. F1 relies on the breadth and depth of AWS services to stream, process, and analyze that flood of data in real-time, and then present it in a meaningful way for F1 global TV viewers. The new “Car Performance Scores” insight will display as an on-screen graphic that provides fans with a complete breakdown of a car’s total performance using four core metrics: Low-Speed Cornering, High-Speed Cornering, Straight Line, and Car Handling. The new graphic will illustrate how those metrics compare from one car to another, enabling race fans to gauge a given car’s relative performance in those different areas and see where each team and driver is leading the pack or losing crucial time to their rivals.

F1 and AWS previously announced six F1 Insights, including Exit Speed, Predicted Pit Stop Strategy, Pit Window, Battle Forecast, Pit Strategy Battle, and Tyre Performance and will roll out the following six additional “F1 Insights powered by AWS” stats as on-screen graphics from July through December of this season, offering fans more visibility into the split-second decision-making and action on the track, as well as behind the pit wall where the team strategists operate:

  • Car Performance Scores: Isolates an individual car’s performance and allows race fans to compare its performance to that of different vehicles head-to-head (debuts July 3-5 at the FORMULA 1 ROLEX GROSSER PREIS VON ÖSTERREICH GRAND PRIX 2020).
  • Ultimate Driver Speed Comparison: Allows race fans to see how their favorite drivers compare to other drivers in history, dating back to 1983, to help determine the fastest driver of all time (debuts August 7-9 at the EMIRATES FORMULA 1 70th ANNIVERSARY GRAND PRIX 2020).
  • High-Speed/Low-Speed Corner Performance: Allows fans to see how well drivers tackle the fastest bends on the track travelling at more than 175 kph/109 mph and slow cornering (below 125 kph/78 mph) compared to other vehicles, which is critical to lap time (debuts August 28-30 at the FORMULA 1 ROLEX BELGIAN GRAND PRIX).
  • Driver Skills Rating: Breaks down and scores driver skills, based on the most important factors for overall performance, to help identify the best “total driver” on the track. By calculating varying subsets of qualifying round performance, starts, race pace, tire management, and overtaking/defending styles, this insight will provide an overall driver ranking (debuts the second half of the season).
  • Car/Team Development & Overall Season Performance: As the season unfolds, this will plot a team’s cumulative performance from race to race to uncover the development rates of each team (debuts the second half of the season).
  • Qualifying and Race Pace Predictions: Gather data from practice and qualifying laps to predict which team is poised for success ahead of each race session. These predictions will create heightened intrigue and excitement for the Saturday qualifying session and Sunday race (debuts the second half of the season).

To create these new insights, Formula 1 will use 70 years of historical race data stored in Amazon Simple Storage Service (Amazon S3), combined with live data that is streamed from sensors on F1 race cars and the trackside to the cloud through Amazon Kinesis, a service for real-time data collection, processing, and analysis. F1 engineers and scientists will use this data to leverage machine learning (ML) models with Amazon SageMaker, AWS’s service for building, training, and deploying ML models. F1 is able to analyze race performance metrics in real-time by deploying those ML models on AWS Lambda, which runs code without the need to provision or manage servers. All of the insights will be integrated into the international broadcast feed of F1 races around the globe, including its digital platform F1.tv, helping fans to understand the split-second decisions and race strategies made by drivers or team strategists that can dramatically affect a race outcome.

“Over the past two years, Formula 1 has embraced AWS’s services to perform intense and dynamic data analysis. The F1 Insights we’re delivering together are bringing fans closer to the track than ever before, and unlocking previously untold stories and insights from behind the pit wall,” said Rob Smedley, Chief Engineer of Formula 1. “We’re excited to be expanding this successful relationship to bring even more insights to life, allowing fans to go deeper into the many ways that drivers and racing teams work together to affect success.”

“Formula 1 racing mixes physics and human performance, yielding powerful, but complex data that AWS is helping them to harness. Our existing relationship with F1 has already produced statistics that have brought fans into the race paddocks, and our study of race car aerodynamics is influencing vehicle designs for the 2022 season,” said Mike Clayville, Vice President, Worldwide Commercial Sales at AWS. “This year, we’re thrilled to extend the power of F1 data in the cloud and unlock new insights that help fans understand more of F1’s rich complexity.”

To learn more about the first 2020 F1 Insight, Car Performance Scores, please click here . For more information about AWS and its involvement with Formula 1, please visit: https://aws.amazon.com/f1/ . For additional news on how AWS is helping Formula 1 develop the next-generation race car, visit: https://aws.amazon.com/f1/news/ .

About Amazon Web Services

For 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 76 Availability Zones (AZs) within 24 geographic regions, with announced plans for nine more Availability Zones and three more AWS Regions in Indonesia, Japan, and Spain. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com .

About Amazon

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews .

About Formula 1®

Formula 1® racing began in 1950 and is the world’s most prestigious motor racing competition, as well as the world’s most popular annual sporting series. The 2020 FIA Formula One World Championship™ runs from March to November and spans 22 races in 22 countries across five continents. Formula One World Championship Limited is part of Formula 1® and holds the exclusive commercial rights to the FIA Formula One World Championship™. Formula 1® is a subsidiary of Liberty Media Corporation (NASDAQ: LSXMA, LSXMB, LSXMK, BATRA, BATRK, FWONA, FWONK) attributed to the Formula One Group tracking stock. The F1 logo, F1 FORMULA 1 logo, FORMULA 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye